BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
4.000
0.00 (0.00%)
At close: Jul 18, 2025

BHIC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
4.731.840.60.07-
Revenue Growth (YoY)
207.22%208.73%761.80%--
Cost of Revenue
1.720.540.110.01-
Gross Profit
3.011.310.480.06-
Selling, General & Admin
2.121.220.740.170.01
Operating Expenses
2.121.220.740.170.01
Operating Income
0.890.09-0.25-0.11-0.01
Other Non Operating Income (Expenses)
----0.06-
Pretax Income
0.890.09-0.25-0.17-0.01
Net Income
0.890.09-0.25-0.17-0.01
Net Income to Common
0.890.09-0.25-0.17-0.01
Shares Outstanding (Basic)
1110821
Shares Outstanding (Diluted)
1111821
Shares Change (YoY)
3.56%25.44%301.99%147.38%-
EPS (Basic)
0.080.01-0.03-0.08-0.01
EPS (Diluted)
0.080.01-0.04-0.08-0.01
Gross Margin
63.64%70.94%81.06%86.01%-
Operating Margin
18.74%4.72%-42.09%-161.99%-
Profit Margin
18.74%4.72%-42.09%-245.81%-
EBIT
0.890.09-0.25-0.11-0.01
EBIT Margin
18.74%4.72%-42.09%-161.99%-
Advertising Expenses
-0.130.11--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.